title: Effect of LH injections on testicular steroidogenesis, cholesterol side-chain cleavage P450 mRNA content and Leydig cell morphology in hypogonadal mice.
abstract: Hypogonadal (hpg) mice have a congenital deficiency of hypothalamic gonadotrophin-releasing hormone (GnRH) and the gonads consequently lack exposure to gonadotrophins during development. We injected male hpg mice with LH for 10 days to investigate whether LH alone can stimulate normal steroidogenesis in these animals. Control animals had an inactive interstitium and very few germ cells. Testicular content of androgens was undetectable by radioimmunoassay in control animals unless a single injection of LH was given 1 h before death, when androgens were just detectable. Control testes incubated in vitro with [3H]pregnenolone demonstrated that without gonadotrophin stimulation pregnenolone was metabolized only to progesterone in significant amounts. Assay for cholesterol side-chain cleavage cytochrome P450 (P450scc) mRNA showed basal expression in saline-treated hpg mouse testis. LH treatment induced hypertrophy and hyperplasia of Leydig cells and division of germ cells. Testicular androgen content increased significantly, with testosterone and androstenedione as the major androgens. LH-treated testes incubated with [3H]pregnenolone in vitro had a greater synthetic capacity for testosterone, suggesting an increase in 17 alpha-hydroxylase/C17-20-lyase activity. Basal and human chorionic gonadotrophin-stimulated androgen production in vitro increased markedly following LH treatment to levels previously described in the normal adult animal. LH treatment caused a rapid and transient increase in the hybridization of P450scc mRNA which was sevenfold greater than that of saline-treated controls when the animals were killed 1 h after the last injection but fell to control levels within 24 h of cessation of treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Human Anatomy, University of Oxford.
authors.forename: I S
authors.initials: IS
authors.lastname: Scott
authors.forename: H M
authors.initials: HM
authors.lastname: Charlton
authors.forename: B S
authors.initials: BS
authors.lastname: Cox
authors.forename: C A
authors.initials: CA
authors.lastname: Grocock
authors.forename: J W
authors.initials: JW
authors.lastname: Sheffield
authors.forename: P J
authors.initials: PJ
authors.lastname: O'Shaughnessy
mesh_terms: D000728:Androgens / Q000096:biosynthesis*; D000735:Androstenedione / Q000096:biosynthesis; D000818:Animals; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000378:metabolism*; D007006:Hypogonadism / Q000378:metabolism*; D007985:Leydig Cells / Q000166:cytology / Q000187:drug effects; D007986:Luteinizing Hormone / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008817:Mice, Mutant Strains; D012333:RNA, Messenger / Q000378:metabolism*; D013737:Testis / Q000378:metabolism*; D013739:Testosterone / Q000096:biosynthesis
chemical_list: D000728:Androgens; D012333:RNA, Messenger; D013739:Testosterone; D000735:Androstenedione; D007986:Luteinizing Hormone; D002786:Cholesterol Side-Chain Cleavage Enzyme